Clinical Trials Browser

Phase 3 × marimastat × Clear all

NCT00003010 2023-06-15

Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following Chemotherapy

Phase 3 Completed

Breast Neoplasms

NCT00003011 2020-04-03

Marimastat Following Chemotherapy in Treating Patients With Small Cell Lung Cancer

Phase 3 Completed

Lung Neoplasms, Small Cell Lung Carcinoma

NCT00002911 2013-12-18

Marimastat in Treating Patients With Stage III Non-small Cell Lung Cancer

Phase 3 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms